[A primitive plasma cell leukemia with immunoglobulin (Ig) E]

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Multiple myeloma is a malignancy of plasma cells.
• Plasma cell leukemia (PCL) is a rare and aggressive subtype of multiple myeloma.
• Immunoglobulin E (IgE) myeloma is an exceptional variant with a poor prognosis.

Observation:

• This case involves primitive plasma cell leukemia (pPCL), which arises de novo.
• The leukemia is characterized by the presence of immunoglobulin E (IgE).

Findings:

• Diagnosis of IgE myeloma requires specific analyses to detect IgE gammopathy.
• Plasma cell leukemia diagnosis is based on blood plasmacytosis exceeding 2 G/L or comprising 20% of leukocytes.

Implications:

• Early and accurate diagnosis of IgE myeloma and PCL is crucial for patient outcomes.
• Understanding rare myeloma variants like IgE myeloma aids in developing targeted therapies.
• This case highlights the importance of specific diagnostic approaches for exceptional hematologic malignancies.